NL129434C - - Google Patents

Info

Publication number
NL129434C
NL129434C NL129434DA NL129434C NL 129434 C NL129434 C NL 129434C NL 129434D A NL129434D A NL 129434DA NL 129434 C NL129434 C NL 129434C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL129434C publication Critical patent/NL129434C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL129434D 1966-03-12 NL129434C (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6603256A NL6603256A (ja) 1966-03-12 1966-03-12

Publications (1)

Publication Number Publication Date
NL129434C true NL129434C (ja)

Family

ID=19795968

Family Applications (2)

Application Number Title Priority Date Filing Date
NL129434D NL129434C (ja) 1966-03-12
NL6603256A NL6603256A (ja) 1966-03-12 1966-03-12

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6603256A NL6603256A (ja) 1966-03-12 1966-03-12

Country Status (13)

Country Link
US (1) US3534041A (ja)
BE (1) BE695304A (ja)
BR (1) BR6787719D0 (ja)
CH (1) CH501647A (ja)
DE (2) DE1795836C2 (ja)
DK (1) DK124824B (ja)
ES (1) ES337526A1 (ja)
FI (1) FI51694C (ja)
FR (1) FR6764M (ja)
GB (1) GB1173783A (ja)
GR (1) GR37262B (ja)
NL (2) NL6603256A (ja)
SE (1) SE331999B (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714148A (en) * 1968-10-15 1973-01-30 Sumitomo Chemical Co Process for preparing dibenzazocine derivatives and salts thereof
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (nl) * 1974-02-09 1986-12-01 Akzo Nv Werkwijze voor het bereiden van 1,2,3,4,10,14b-hexahydrodibenzo(c,f)pyrazino (1,2-a)azepine derivaten.
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4128641A (en) * 1975-07-31 1978-12-05 Hzi Research Center Inc. Tetracyclic psychotropic drug
NL7610942A (nl) * 1976-10-02 1978-04-04 Akzo Nv Werkwijze voor het bereiden van 1,4-diazepine derivaten.
NL7809726A (nl) * 1978-09-26 1980-03-28 Akzo Nv Nieuwe tetracyclische verbindingen.
EP0055546B1 (en) * 1980-12-31 1984-08-01 Beecham Group Plc Pentacyclic compounds, processes for their preparation and their use
EP0088575B1 (en) * 1982-03-05 1986-12-30 Beecham Group Plc Pentacyclic compounds
EP0090552A3 (en) * 1982-03-27 1984-04-25 Beecham Group Plc Pentacyclic compounds
EP0126343A1 (en) * 1983-05-18 1984-11-28 Beecham Group Plc Treatment of diarrhoea
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3856387T2 (de) * 1987-04-10 2000-05-11 Monash University, Clayton 1,2,3,4,10,14b-HEXAHYDRODIBENZO-c,f]PYRAZINO-1,2-a]AZEPINO-DERIVATE
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
US5189161A (en) * 1989-08-07 1993-02-23 Hoechst Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
ATE112491T1 (de) 1990-09-13 1994-10-15 Akzo Nobel Nv Stabilisierte feste chemische zusammensetzungen.
US5859012A (en) * 1996-04-03 1999-01-12 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
WO1999016769A1 (en) * 1997-09-26 1999-04-08 Monash University Resolution of optically-active compounds
US6548522B1 (en) 1999-10-12 2003-04-15 Hoffmann-La Roche Inc. Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US6723445B2 (en) 2001-12-31 2004-04-20 Canon Kabushiki Kaisha Organic light-emitting devices
CA2537402C (en) 2003-09-12 2009-05-05 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
JP5254620B2 (ja) 2004-12-03 2013-08-07 メルク・シャープ・アンド・ドーム・コーポレーション Ｃｂ１アンタゴニストとしての置換ピペラジン
AU2006269231A1 (en) 2005-07-08 2007-01-18 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
AU2006311577B2 (en) 2005-11-09 2013-02-07 Zalicus Inc. Methods, compositions, and kits for the treatment of medical conditions
BRPI0706623A2 (pt) 2006-01-18 2011-04-12 Schering Corp moduladores de receptor canabinóide
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
US20080171750A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation Of Neurogenesis With Use of Modafinil
WO2009005646A2 (en) 2007-06-28 2009-01-08 Schering Corporation Substituted piperazines as cb1 antagonists
EP2288345B1 (en) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Psycho-pharmaceuticals
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004975A (en) * 1961-10-17 Cochs
US3005789A (en) * 1955-10-11 1961-10-24 Gen Aniline & Film Corp Drier composition
US3151116A (en) * 1961-11-03 1964-09-29 Ciba Geigy Corp Certain 2-aza-indolo [2, 3-alpha] quinolizine compounds
US3328396A (en) * 1961-11-09 1967-06-27 Sterling Drug Inc 3, 8-di-substituted-3, 8-diazabicyclo [3.2.1] octanes
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3317524A (en) * 1965-02-04 1967-05-02 American Home Prod Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes

Also Published As

Publication number Publication date
FI51694B (ja) 1976-11-30
FR6764M (ja) 1969-03-10
SE331999B (ja) 1971-01-25
DE1695556B2 (de) 1980-10-30
BR6787719D0 (pt) 1973-12-26
BE695304A (ja) 1967-09-11
DE1695556A1 (de) 1972-01-20
FI51694C (fi) 1977-03-10
DE1695556C3 (de) 1981-06-25
GB1173783A (en) 1969-12-10
CH501647A (de) 1971-01-15
GR37262B (el) 1969-05-10
DK124824B (da) 1972-11-27
DE1795836B1 (de) 1977-11-24
ES337526A1 (es) 1968-03-01
US3534041A (en) 1970-10-13
DE1795836C2 (de) 1978-07-20
NL6603256A (ja) 1967-09-13

Similar Documents

Publication Publication Date Title
AU5917865A (ja)
AU424443B2 (ja)
AU428063B2 (ja)
AU433222B2 (ja)
AU417216B2 (ja)
AU421822B2 (ja)
AU5895065A (ja)
AU6703465A (ja)
AU612166A (ja)
BE674777A (ja)
BE654686A (ja)
BE692292A (ja)
BE692197A (ja)
BE692081A (ja)
BE691889A (ja)
BE690438A (ja)
BE686278A (ja)
BE685605A (ja)
BE675139A (ja)
BE675084A (ja)
BE674987A (ja)
BE674882A (ja)
BE674792A (ja)
BE692947A (ja)
BE674713A (ja)